洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2500110717】WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery

基本信息
登记号

ChiCTR2500110717

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-10-20

临床申请受理号

/

靶点

/

适应症

Colorectal Cancer

试验通俗题目

WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery

试验专业题目

WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

1.To develop and implement a technology-assisted prehabilitation for CRC patient undergoing elective surgery. 2.To examine the effects of the technology-assisted prehabilitation on postoperative complications, length of stay (LOS), physical activity (PA), nutritional status, gastrointestinal (GI) recovery and psychological well-being. 3.To evaluate the feasibility and patients' perception towards the technology-assisted prehabilitation.

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

A computer-based randomization will be utilized to allocate patients into either one group. Eligible participants will be randomly assigned in a 1:1 ratio to either control group or intervention group. Block randomization was performed through a computer-generated sequence, and serial and opaque with sealed envelopes will be prepared in by independent staff not involved in clinical care or screening or assessment, in which will be used to conceal the sequence until the intervention as assigned at the outpatient preoperative clinic

盲法

Assessor will be blinded for the allocation of the participants and intervention.

试验项目经费来源

None

试验范围

/

目标入组人数

50

实际入组人数

/

第一例入组时间

2025-09-10

试验终止时间

2026-12-31

是否属于一致性

/

入选标准

Patients (1) aged over 18, (2) scheduled for elective colorectal cancer surgery as primary treatment, (3) possess a smart technology with internet plan or WIFI access, (4) able to use WhatsApp application with read, write and interact, (5) can understand Chinese (Cantonese) and follow instructions.;

排除标准

Patients with (1) expected surgery date less than 21 days, (2) identified cognitive disorder, (3) respiratory disease or (4) musculoskeletal problems, that is, showed difficulties in understanding the study procedures, providing informed consent or following instructions, in their medical records, (5) requiring neoadjuvant therapy. Participants will be also excluded if their surgery is cancelled (as judged by surgeon or patient refused operation) after randomization.;

研究者信息
研究负责人姓名
试验机构

The Chinese University of Hong Kong

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

The Chinese University of Hong Kong的其他临床试验

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用